These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1281852)

  • 1. A child with valproic acid-associated carnitine deficiency and carnitine-responsive cardiac dysfunction.
    Bratton SL; Garden AL; Bohan TP; French JW; Clarke WR
    J Child Neurol; 1992 Oct; 7(4):413-6. PubMed ID: 1281852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs.
    Verrotti A; Greco R; Morgese G; Chiarelli F
    Int J Clin Lab Res; 1999; 29(1):36-40. PubMed ID: 10356662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnitine deficiency during valproic acid treatment.
    Van Wouwe JP
    Int J Vitam Nutr Res; 1995; 65(3):211-4. PubMed ID: 8830002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carnitine deficiency and hyperammonemia associated with valproic acid therapy.
    Ohtani Y; Endo F; Matsuda I
    J Pediatr; 1982 Nov; 101(5):782-5. PubMed ID: 6813444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of long-term valproic acid administration on the efficiency of carnitine reabsorption in humans.
    Stadler DD; Bale JF; Chenard CA; Rebouche CJ
    Metabolism; 1999 Jan; 48(1):74-9. PubMed ID: 9920148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between renal tubular dysfunction and serum carnitine deficiency in cases with valproate therapy].
    Ono H
    No To Hattatsu; 2009 Sep; 41(5):363-5. PubMed ID: 19764458
    [No Abstract]   [Full Text] [Related]  

  • 7. Carnitine, valproate, and toxicity.
    Coulter DL
    J Child Neurol; 1991 Jan; 6(1):7-14. PubMed ID: 2002205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid impairs carnitine uptake in cultured human skin fibroblasts. An in vitro model for the pathogenesis of valproic acid-associated carnitine deficiency.
    Tein I; DiMauro S; Xie ZW; De Vivo DC
    Pediatr Res; 1993 Sep; 34(3):281-7. PubMed ID: 8134167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of carnitine supplementation during valproic acid therapy.
    Raskind JY; El-Chaar GM
    Ann Pharmacother; 2000 May; 34(5):630-8. PubMed ID: 10852092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of carnitine supplementation in pediatric patients receiving valproic acid therapy.
    Davis D; Farrington E
    Pediatr Nurs; 1992; 18(3):264-5. PubMed ID: 1625956
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum carnitine, beta-hydroxybutyrate and ammonia levels during valproic acid therapy.
    Toksoy HB; Tanzer FN; Atalay A
    Turk J Pediatr; 1995; 37(1):25-9. PubMed ID: 7732605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal handling of carnitine in children with carnitine deficiency and hyperammonemia associated with valproate therapy.
    Matsuda I; Ohtani Y; Ninomiya N
    J Pediatr; 1986 Jul; 109(1):131-4. PubMed ID: 3088240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet.
    Coppola G; Epifanio G; Auricchio G; Federico RR; Resicato G; Pascotto A
    Brain Dev; 2006 Jul; 28(6):358-65. PubMed ID: 16376041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carnitine deficiency caused by valproic acid.
    Castro-Gago M; Camiña F; Rodríguez-Segade S
    J Pediatr; 1992 Mar; 120(3):496. PubMed ID: 1538306
    [No Abstract]   [Full Text] [Related]  

  • 15. [Carnitine deficiency as an adverse effect of treatment with valproic acid].
    Opala G
    Neurol Neurochir Pol; 1990; 24(3-4):244-5. PubMed ID: 2131422
    [No Abstract]   [Full Text] [Related]  

  • 16. [Carnitine deficiency].
    Schmidt-Sommerfeld E; Penn D
    Monatsschr Kinderheilkd; 1986 May; 134(5):224-31. PubMed ID: 3014317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle carnitine deficiency in patients using valproic acid.
    Shapira Y; Gutman A
    J Pediatr; 1991 Apr; 118(4 Pt 1):646-9. PubMed ID: 2007943
    [No Abstract]   [Full Text] [Related]  

  • 18. Sodium valproate -- induced skeletal myopathy.
    Kasturi L; Sawant SP
    Indian J Pediatr; 2005 Mar; 72(3):243-4. PubMed ID: 15812121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secondary carnitine deficiency].
    Yorifuji S
    Ryoikibetsu Shokogun Shirizu; 2001; (36):51-3. PubMed ID: 11596448
    [No Abstract]   [Full Text] [Related]  

  • 20. Carnitine deficiency: a possible mechanism for valproate hepatotoxicity.
    Coulter DL
    Lancet; 1984 Mar; 1(8378):689. PubMed ID: 6142383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.